Evaluation of the accuracy of prostate cancer diagnosis with carbohydrate biomarker test

Evaluation of the accuracy of prostate cancer diagnosis with carbohydrate biomarker test - Evaluation of the accuracy of prostate cancer diagnosis with carbohydrate biomarker test

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000041207

Enrollment

204

Registered

2020-07-25

Start date

2018-10-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Suspected prostate cancer

Interventions

None listed

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: 1. Prostate cancer suspected person whose serum PSA level with and larger than 0.1ng/mL. 2. Prostate cancer suspected person who are able to be receive MRI-TRUS fusion image-guided biopsy. 3. Prostate cancer suspected person who agree with informed consent.

Exclusion criteria

Exclusion criteria: 1. Person who are considered as worsen their health condition due to blood test. 2. Person who are regarded as inappropriate for the study by the researcher.

Design outcomes

Primary

Measure	Time frame
Relationship between PSA Gi, serum PSA level, MRI finding, and pathological findings of the prostate biopsy	—

Countries

Japan

Contacts

Public ContactSunao Shoji

Tokai University School of Medicine

sunashoj@mail.goo.ne.jp0463-93-1121

Outcome results